Drug intelligence / Profile preview

Algocur

Development stage
Unknown
Lead developer
Pharmextracta
Modality
Small Molecules
Administration
Oral
01

Overview

Algocur is a nutraceutical supplement developed by Omeopiacenza (Pharmextracta) that utilizes a curcumin phytosome formulation (Meriva). This delivery system complexes curcumin with phosphatidylcholine to significantly enhance its oral bioavailability compared to standard curcumin extracts. Curcumin, the primary active constituent, exerts potent anti-inflammatory and antioxidant effects by modulating multiple molecular targets, including the inhibition of nuclear factor-kappa B (NF-κB), cyclooxygenase-2 (COX-2), and various pro-inflammatory cytokines such as TNF-α and IL-6. Algocur is primarily marketed in Italy as a supportive treatment for inflammatory conditions, pain management, and as an adjuvant in oncology to mitigate treatment-related side effects and support overall health.

Brand names
Algocur
Other names
Curcumin PhytosomeMeriva
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Algocur.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algocur.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call